Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00216_DB00582> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00216_DB00582 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00216_DB00582 label "DDI between Eletriptan and Voriconazole - Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of eletriptan by decreasing its metabolism. Consider avoiding administration of the two agents within 72 hours of each other. Monitor for changes in the therapeutic and adverse effects of eletriptan if voriconazole is initiated, discontinued or dose changed. [drugbank_resource:DB00216_DB00582]" assertion.
- drugbank_resource:DB00216_DB00582 identifier "drugbank_resource:DB00216_DB00582" assertion.
- drugbank_resource:DB00216_DB00582 title "DDI between Eletriptan and Voriconazole - Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of eletriptan by decreasing its metabolism. Consider avoiding administration of the two agents within 72 hours of each other. Monitor for changes in the therapeutic and adverse effects of eletriptan if voriconazole is initiated, discontinued or dose changed." assertion.